Zhongshan Chuangkang Electronic Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Zhongshan Chuangkang Electronic Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include CLEEMUZIN. The owner is based in Zhongshan.

No. 2, 2nd Floor, No. 12, Baosheng 1st Street, Xinsheng Village, Xiaolan Town,

Zhongshan 528414 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

CLEEMUZIN
CLEEMUZIN
Registered 2025

Trademark Classifications

Zhongshan Chuangkang Electronic Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does Zhongshan Chuangkang Electronic Technology Co., Ltd. have?

Zhongshan Chuangkang Electronic Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Zhongshan Chuangkang Electronic Technology Co., Ltd. file in?

Zhongshan Chuangkang Electronic Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 25 (Clothing). Class 25 covers clothing, footwear, headgear.

What are Zhongshan Chuangkang Electronic Technology Co., Ltd.'s most well-known trademarks?

Zhongshan Chuangkang Electronic Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as CLEEMUZIN. These are among 1 currently registered trademark in the portfolio.

What is Zhongshan Chuangkang Electronic Technology Co., Ltd.'s trademark registration success rate?

Zhongshan Chuangkang Electronic Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.